Vera Therapeutics, Inc. - CL A (VERA)

Historical Portfolio Holders from Q2 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / CL A
Shares, excl. options Q1 2024
49.6 M
Holdings value Q1 2024
$2.14 B
Value change Q1 2024
+$450 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
152
Number of buys Q1 2024
116
Number of sells Q1 2024
-37
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
-0.004%
CUSIP
92337R101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 49.6 M $2.14 B +$450 M $43.12 153
2023 Q4 40.4 M $621 M +$28.9 M $15.38 92
2023 Q3 39.3 M $538 M +$9.59 M $13.71 83
2023 Q2 38.1 M $612 M +$42.6 M $16.05 77
2023 Q1 37.4 M $290 M +$138 M $7.76 69
2022 Q4 21.2 M $411 M -$8 M $19.35 56
2022 Q3 21.4 M $457 M +$21 M $21.31 52
2022 Q2 20.3 M $276 M +$6.51 M $13.61 46
2022 Q1 17.4 M $408 M +$122 M $23.49 48
2021 Q4 14 M $374 M +$10.5 M $26.72 36
2021 Q3 14.7 M $252 M +$4.18 M $17.35 31
2021 Q2 14.5 M $186 M +$186 M $13.25 21